Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis (Q34393259)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

Paolo Vercellini

1

object named as

P Vercellini

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

O De Giorgi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S Oldani

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

I Cortesi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S Panazza

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

P G Crosignani

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 August 1996

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

American Journal of Obstetrics and Gynecology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

175

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

396-401

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Buserelin versus danazol in the treatment of endometriosis-associated infertility

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Improving the classification of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Drug regulation in the United States and the United Kingdom: the Depo-Provera story

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Resea

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Medical treatment of mild endometriosis in infertile women: analysis of a failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Depression in users of depo-medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Bone density in women receiving depot medroxyprogesterone acetate for contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

DMPA and bone density.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

Treatment of endometriosis with estrogen-progestin combination and progestogens alone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970152-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9378(96)70152-7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34393259&oldid=1983174492"